Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies.
about
MicroRNA-26a is a novel regulator of vascular smooth muscle cell functionLentiviral-Mediated shRNA Silencing of PDE4D Gene Inhibits Platelet-Derived Growth Factor-Induced Proliferation and Migration of Rat Aortic Smooth Muscle CellsMicroRNA-21 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting activator protein-1.MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease.Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteinsTissue transglutaminase promotes PDGF/PDGFR-mediated signaling and responses in vascular smooth muscle cellsCB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.Phenotypic transformation of smooth muscle cells from porcine coronary arteries is associated with connexin 43Iroquois homeobox transcription factor (Irx5) promotes G1/S-phase transition in vascular smooth muscle cells by CDK2-dependent activationEpigenetics: novel mechanism of pulmonary hypertension.Association between PDE4D gene and ischemic stroke: recent advancements.Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA.miRNA‑504 inhibits p53‑dependent vascular smooth muscle cell apoptosis and may prevent aneurysm formationA novel role of Brg1 in the regulation of SRF/MRTFA-dependent smooth muscle-specific gene expression.IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II.Tunicamycin inhibits PDGF-BB-induced proliferation and migration of vascular smooth muscle cells through induction of HO-1.
P2860
Q24624403-438CC857-D30B-4AA7-ACF4-149719E9A4B9Q28565953-8EAE8CA4-D4E7-411A-BE5C-B311F63105C5Q34420579-4B403D2D-FC26-46BE-9449-155142493834Q35007985-2848D40B-E17E-4B5A-B7F6-49B8C518DA3EQ35110887-48D51E6F-C99A-46EF-828B-DA0CFB7EEBFDQ35535644-DFD1F9C6-AE53-4B6B-961D-1E398DE36985Q36416330-626489A6-880E-43B3-9306-58CCD763CF99Q37032237-354B9ABF-7B97-4CD6-90BB-1AB1EE596EBAQ37457069-036F1126-8091-436D-AAA0-C30D3DCCE8F1Q38139834-1AE09A14-9A54-4BF9-AF38-EEDCE85A5EA6Q38500866-327FE48D-4285-4A92-8E39-7E8BD4B4D9F5Q41531960-DF3FBFF7-C6D9-40F6-AD2E-31FEF8302C1FQ42546641-C3590269-5FFE-47B8-AB20-A9FCA67384F8Q42827021-5CB52C9E-00AF-489A-B6C1-7840891E3881Q43246055-9CEDAD2A-85AE-404C-BB87-6855055D5C0CQ53155421-AC8ED541-3D03-487B-A9B6-BE1CA4229E48
P2860
Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Regulation of smooth muscle ce ...... urrent therapeutic strategies.
@ast
Regulation of smooth muscle ce ...... urrent therapeutic strategies.
@en
type
label
Regulation of smooth muscle ce ...... urrent therapeutic strategies.
@ast
Regulation of smooth muscle ce ...... urrent therapeutic strategies.
@en
prefLabel
Regulation of smooth muscle ce ...... urrent therapeutic strategies.
@ast
Regulation of smooth muscle ce ...... urrent therapeutic strategies.
@en
P2860
P356
P1476
Regulation of smooth muscle ce ...... urrent therapeutic strategies.
@en
P2093
Xinjiang Cai
P2860
P304
P356
10.1586/14779072.4.6.789
P577
2006-11-01T00:00:00Z